T. Rowe Price Associates’s Danimer Scientific, Inc. DNMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-707
Closed -$31K 3056
2024
Q1
$31K Buy
707
+191
+37% +$7.91K ﹤0.01% 2912
2023
Q4
$22K Buy
516
+60
+13% +$3.26K ﹤0.01% 2871
2023
Q3
$38K Hold
456
﹤0.01% 2808
2023
Q2
$44K Buy
456
+40
+10% +$5.13K ﹤0.01% 2818
2023
Q1
$58K Buy
416
+9
+2% +$823 ﹤0.01% 2770
2022
Q4
$29K Buy
407
+51
+14% +$4.82K ﹤0.01% 2861
2022
Q3
$43K Buy
+356
New +$63.4K ﹤0.01% 2857
2021
Q4
Sell
-476
Closed -$311K 3051
2021
Q3
$311K Buy
476
+43
+10% +$31.6K ﹤0.01% 2565
2021
Q2
$434K Sell
433
-2,315
-84% -$2.31M ﹤0.01% 2447
2021
Q1
$4.15M Buy
+2,748
New +$4.46M ﹤0.01% 1507

Other funds holding DNMR

T. Rowe Price Associates's DNMR Position: Q2 2024 in Review

T. Rowe Price Associates sold out of Danimer Scientific, Inc. (DNMR) in Q2 2024, closing a stake of 707 shares — an estimated $31K sold.

T. Rowe Price Associates first reported a position in DNMR in Q1 2021 and held it in 10 quarters. The position peaked at $4.15M in Q1 2021. 139 funds tracked by Wall St. Rank hold DNMR as of Q2 2024.

  • T. Rowe Price Associates reported no remaining Danimer Scientific, Inc. position as of Q2 2024 after selling out during the quarter.
  • T. Rowe Price Associates sold 707 Danimer Scientific, Inc. shares in Q2 2024, an estimated $31K.
  • T. Rowe Price Associates first reported a position in Danimer Scientific, Inc. in Q1 2021 and held it in 10 quarters.
  • T. Rowe Price Associates's Danimer Scientific, Inc. position peaked at $4.15M in Q1 2021.
  • 139 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q2 2024.

Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.